These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1575822)

  • 1. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
    Kissebah AH; Alfarsi S; Evans DJ
    Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
    Austin MA; Brunzell JD; Fitch WL; Krauss RM
    Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
    Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
    Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
    Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
    Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.
    Calabresi L; Donati D; Pazzucconi F; Sirtori CR; Franceschini G
    Atherosclerosis; 2000 Feb; 148(2):387-96. PubMed ID: 10657575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia.
    Demacker PN; Veerkamp MJ; Bredie SJ; Marcovina SM; de Graaf J; Stalenhoef AF
    Atherosclerosis; 2000 Dec; 153(2):483-90. PubMed ID: 11164438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
    Haffner SM; Kushwaha RS; Hazzard WR
    Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
    Hokanson JE; Austin MA; Zambon A; Brunzell JD
    Arterioscler Thromb; 1993 Mar; 13(3):427-34. PubMed ID: 8443147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.
    Juo SH; Bredie SJ; Kiemeney LA; Demacker PN; Stalenhoef AF
    Am J Hum Genet; 1998 Aug; 63(2):586-94. PubMed ID: 9683593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia.
    Hirano T; Nohtomi K; Sato Y; Kamata K; Ito Y
    Atherosclerosis; 2009 Aug; 205(2):603-7. PubMed ID: 19201411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
    Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
    Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.